The 37th ESCRS, one of the leading surgical ophthalmology events in the calendar, was held in Paris a few weeks ago. As well as being a fantastic opportunity for attendees to take part in clinical education and training sessions, the big names in ophthalmic cataract and refractive surgery were in attendance with their latest technologies.
With this in mind, we thought we’d take a look at the event and what we think were some of the key pieces of technology showcased there.
Technologies on display
As one of the leading events for surgical ophthalmology, there’s little wonder that some of the most exciting things going on were the announcements and demonstrations of some of the new technologies.
These are the ones that stood out to us the most…
Alcon introduced a portfolio of minimally invasive cataract surgery technologies at the event, including additions to their Centurion Vision System. They also exhibited their LuxOR ophthalmic microscope. With technologies like this there’s a reason Alcon are one of the biggest names in the space.
Johnson & Johnson have announced their ‘revolutionary’ Tecnis Synergy IOL, an intraocular lens for patients with cataracts.
Santen showed off their entry into the IOL market, the LENTIS Comfort for cataract treatment, the first product of its type for the company.
Carl Zeiss introduced the EQ Workplace which offers surgeons a digital solution to connect and streamline the refractive cataract workflow. Not only this, they’ve also expanded their OCT portfolio with the Cirrus 6000.
Zeimer presented the new Aquariuz Ablation Laser which can be integrated with other lasers and diagnostic devices. It’s yet to be CE marked and FDA cleared, but it could be a competitor to some of the leading portfolios in future.
BVI, through their subsidiary PhysIOL, announced the FineVision Trumf IOL to the European market. Their stand was near some of the biggest names at ESCRS, they’re a force to be reckoned with.
Rayner introduced their RayOne Trifocal Toric which follows on from their launch at ESCRS 2017. Key surgeons in the ophthalmology space have praised the device this year.
In 2019 the market has had a lot of focus on age-related macular degeneration. A lot of talk that has come out of ESCRS indicates that the major industry focus for 2020 is likely to be Myopia… it’ll be interesting to see what unfolds and what technologies are on display at next years’ event. Plus, with AAO 2019 currently underway in San Francisco I’m sure there will be some exciting new products coming to the market in 2020.
It’s been great to hear about all the new launches that have come out of the latest ESCRS, it’s certainly an interesting time to be involved in the world of eye care.
What do you think the most exciting things to come out of the event were? Get in touch with me on email@example.com